Results of an analysis that validated the use of the GVS to determine vulnerability in older patients with ovarian cancer.
The stigma patients with HIV face has been shown to negatively effect their experiences while undergoing cancer care.
Agreement between patient- and physician-reported adverse effects during phase 1 clinical trials varies from poor to fair.
Although cancer survivors report positive quality of life outcomes, patients with colorectal cancer tend to report dissatisfaction with their quality of life and at least one survivorship issue.
A study comparing amount of 5-FU found on connector devices and protective gloves demonstrated which device had the lowest contamination, as well as the importance of wearing personal protective equipment.
A literature search covering 30 years revealed a dearth of studies focused on the concept analysis of psychological distress in patients with advanced cancer.
An analysis of patients with NSCLC and brain metastases at diagnosis found intracranial pressure and seizures had no impact, but other neurologic defects had an effect on overall survival.
An assessment tool developed to capture adverse events in hospitalized patients with cancer identified not only a high rate of care-related harms but that only a small percentage of those were preventable.
Researchers identify trends in use of complementary medicine among patients with breast, colorectal, or lung cancer while participating in phase 3 clinical trials.
Patient-specific, individualized coaching was found to provide needed support for patients with recurrent breast cancer.
Researchers sought to determine if practicing Kegel exercises, a common pelvic-floor exercise, could prevent urinary and fecal incontinence in patients with prostate cancer.
Researchers sought to determine if chemotherapy and radiation therapy increased the risk of stomal complications in ostomy patients.
A quasi-experimental study sought to determine if early vaginal moisturizing eases vaginal dryness and pain associated with PDR brachytherapy for cervical cancer.